Suicidal Ideation in Multiple Sclerosis

Archives of Physical Medicine and Rehabilitation

Volumn 87, Issue 8, 2006, Pages 1073-1078

  Turner, Aaron P ^a,b   Williams, Rhonda M ^a,b   Bowen, James D ^a,c   Kivlahan, Daniel R ^a,b   Haselkorn, Jodie K ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Depression; Multiple sclerosis; Rehabilitation; Suicide

Indexed keywords

ADULT; ANHEDONIA; ARTICLE; BLADDER FUNCTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRIVING ABILITY; ELECTRONIC MEDICAL RECORD; ENTEROPATHY; FEMALE; GOVERNMENT; HEALTH SURVEY; HUMAN; INTESTINE FUNCTION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; PATIENT MOBILITY; PHYSICAL DISABILITY; POSTAL MAIL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOCIAL SUPPORT; SUICIDAL IDEATION; UNITED STATES;

CHI-SQUARE DISTRIBUTION; DEPRESSION; HUMANS; LOGISTIC MODELS; MULTIPLE SCLEROSIS; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SOCIAL SUPPORT; SUICIDE; UNITED STATES; VETERANS;

EID: 33746287214     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2006.04.021     Document Type: Article

References (50)

1. Lucchinetti C., Bruck W., Rodriguez M., and Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 6 (1996) 259-274
2. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis. guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50 (2001) 121-127
3. Noseworthy J., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
4. Reingold S.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 59 (2002) 294 author reply 294-5
5. Aronson K. Quality of life among persons with multiple sclerosis and their caregivers. Neurology 48 (1996) 74-80
6. Goodkin D.E. The natural history of multiple sclerosis (1992), Springer-Verlag, New York
7. Williams R.M., Turner A.P., Hatzakis M., Bowen J.D., Rodriquez A.A., and Haselkorn J.K. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 64 (2005) 75-80
8. Minden S.L., Orav J., and Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 9 (1987) 426-434
9. Siegert R., and Abernethy D. Depression in multiple sclerosis. a review. J Neurol Neurosurg Psychiatry 76 (2006) 469-475
10. Sadovnick A.D., Eisen K., Ebers G.C., and Paty D.W. Cause of death in patients attending multiple sclerosis clinics. Neurology 41 (1991) 1193-1196
11. Stenager E.N., Stenager E., Koch-Henriksen N., et al. Suicide and multiple sclerosis. an epidemiological investigation. J Neurol Neurosurg Psychiatry 55 (1992) 542-545
12. Fredrikson S., Cheng Q., Jiang G.X., and Wasserman D. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 22 (2003) 146-152
13. Fisk J.D., Morehouse S.A., Brown M.G., Skedgel C., and Murray T.J. Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 25 (1998) 230-235
14. Stenager E.N., Koch-Henriksen N., and Stenager E. Risk factors for suicide in multiple sclerosis. Psychother Psychosom 65 (1996) 86-90
15. Anderson R.N., Kochanek K.D., and Murphy S.L. Report of final mortality statistics (1997), National Center for Health Statistics, Hyattsville
16. Stenager E.N., and Stenager E. Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49 (1992) 1296-1303
17. Goldstein R.B., Black D.W., Nasrallah A., and Winokur G. The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry 48 (1991) 418-422
18. Kessler R.C., Berglund P., Borges G., Nock M., and Wang P.S. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 293 (2005) 2487-2495
19. Kessler R.C., Borges G., and Walters E.E. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 56 (1999) 617-626
20. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 59 (2002) 674-678
21. Luoma J.B., Martin C.E., and Pearson J.L. Contact with mental health and primary care providers before suicide. a review of the evidence. Am J Psychiatry 159 (2002) 909-916
22. Patten S.B., Metz L.M., and SPECTRIMS Study Group. Interferon beta1a and depression in secondary progressive MS. data from the SPECTRIMS trial. Neurology 59 (2002) 744-746
23. Mohr D., and Goodkin D. Treatment of depression in multiple sclerosis. review and meta-analysis. Clin Psychol 6 (1999) 1-9
24. Wallin M.T., Wilken J.A., Turner A.P., Williams R.M., and Kane R. Depression and multiple sclerosis. review of a lethal combination. J Rehabil Res Dev 43 (2006) 45-61
25. U.S. Preventive Service Task Force. Screening for depression. recommendations and rationale (2002), Agency for Healthcare Research and Quality, Rockville May
26. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
27. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9. validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
28. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington (DC)
29. Williams J.W., Noel P.H., Cordes J.A., Ramirez G., and Pignone M. Is this patient clinically depressed?. JAMA 287 (2002) 1160-1170
30. Sherbourne C.D., and Stewart A.L. The MOS social support survey. Soc Sci Med 32 (1991) 705-714
31. Schwartz C.E., Vollmer T., Lee H., and North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology 52 (1999) 63-70
32. Vollmer T.L., Ni W., Stanton S., and Hadjimichael O. The NARCOMS patient registry. a resource for investigators. Int J MS Care 1 (1999) 12-15
33. Corson K., Gerrity M.S., and Dobscha S.K. Screening for depression and suicidality in a VA primary care setting. 2 items are better than 1 item. Am J Manag Care 10 11 Pt 2 (2004) 839-845
34. Berman A., and Samuels L. Suicide among people with multiple sclerosis. J Neurol Rehabil 7 (1993) 53-62
35. Beck A.T., Steer R.A., Kovacs M., and Garrison B. Hopelessness and eventual suicide. a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 142 (1985) 559-563
36. Patten S.B., and Metz L.M. Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis. Int J Psychiatry Med 32 (2002) 155-165
37. Bongar B. The suicidal patient. clinical and legal standards of care (1991), American Psychological Association, Washington (DC)
38. Weissman M.M., Bland R.C., Canino G.J., et al. Prevalence of suicide ideation and suicide attempts in nine countries. Psychol Med 29 (1999) 9-17
39. Rich C.L., Warstadt G.M., Nemiroff R.A., Fowler R.C., and Young D. Suicide, stressors, and the life cycle. Am J Psychiatry 148 (1991) 524-527
40. Moscicki E.K. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am 20 (1997) 499-517
41. Lana-Peixoto M.A., Teixeira Jr. A.L., and Haase V.G. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis. Arq Neuropsiquiatr 60 3-B (2002) 721-724
42. Klapper J.A. Interferon beta treatment of multiple sclerosis. [letter]. Neurology 44 (1994) 188
43. Conwell Y., Duberstein P.R., and Caine E.D. Risk factors for suicide in later life. Biol Psychiatry 52 (2002) 193-204
44. Gaynes B.N., West S.L., Ford C.A., Frame P., Klein J., and Lohr K.N. Screening for suicide risk in adults. a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 140 (2004) 822-835
45. Schiffer R., and Wineman N. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147 (1990) 1493-1497
46. Mohr D., Boudewyn A., Goodkin D., Bostrom A., and Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69 (2001) 942-949
47. Crawford J., and McIvor G. Stress management for multiple sclerosis patients. Psychol Rep 61 (1987) 423-429
48. Larcombe N., and Wilson P. An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry 145 (1984) 366-371
49. Foley F.W., Bedell J.R., LaRocca N.G., Scheinberg L.C., and Reznikoff M. Efficacy of stress-inoculation training in coping with multiple sclerosis. J Consult Clin Psychol 55 (1987) 919-922
50. Mohr D., Likosky W., Bertagnolli A., et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 68 (2000) 356-361